Verrica Pharmaceuticals Reports Progress on Molluscum Treatment and Pipeline Development
WEST CHESTER, PA — Verrica Pharmaceuticals Inc. (Nasdaq: VRCA) has provided an update on the commercial strategy for its flagship product YCANTH, a treatment for molluscum contagiosum. The company reported strong …
Verrica Pharmaceuticals Reports Progress on Molluscum Treatment and Pipeline Development Read More